최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기한국식품과학회지 = Korean journal of food science and technology, v.47 no.4, 2015년, pp.492 - 498
이경수 ((주)두한바이오) , 이은경 ((주)두한바이오) , 김신연 (중원대학교 의생명과학과) , 김태환 (중원대학교 의생명과학과) , 김현표 (중원대학교 의생명과학과)
Testosterone deficiency syndrome (TDS) is normally observed in elderly men and is a clinical and biochemical syndrome, characterized by a decline in plasmic testosterone levels resulting in a significant decrease in quality of life. The aim of this study was to evaluate the effect of a mixed extract...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
야관문을 부르는 다른 이름은? | 호로파는 예로 부터 방광과 신장 등을 치료하는 데 사용되었으며, 최근 연구결 과에 따르면 남성의 정력증진 및 몸 속의 혈당과 인슐린의 균형을 유지하는 데에도 효과가 있고, 체중조절에도 효과가 있는 것으로 확인되어 활발히 연구가 진행 중에 있다(18-20). 야관문 (Lespedeza cuneate)은 콩과의 싸리 속에 속하는 식물로 비수리라 고도 하며, 명칭에 밤에 빗장을 열어준다는 의미를 가지고 있어 한방에서 양기부족, 조루증을 비롯하여 기침, 천식 등에 활용되어 왔다. 특히 야관문이 산화질소-cGMP계를 통한 내피세포 의존성 혈관이완작용이 있고, 야관문 메탄올 추출물의 n-hexane층이 토끼의 음경해면체 평활근에 대한 이완효과가 있는 것으로 보고되어 심혈관 질환과 발기부전의 치료에 활용할 수 있는 식물로 알려져 있다(21,22). | |
최근 남성 갱년기를 부르는 명칭은? | 남성갱년 기는 1939년 Werner(9)가 50대 남성에서 잦은 피로감, 성기능 감소, 안면 홍조, 기억력 감퇴, 우울증 등의 복합 증상을 ‘male climacteric’이라고 칭한 데서 유래하였다. 최근에는 late onset of hypogonadism, testosterone deficiency syndrome (TDS)으로 부르고 있다. 남성 갱년기에서 남성호르몬 부족은 전 세계적으로 학술적 관심과 논쟁의 주제가 되고 있다. | |
호로파란? | 호로파(Fenugreek Seeds)는 콩과 식물인 호로파의 여문 씨를 말린 것으로, 예부터 약초로 사용되었으며 알칼로이드, 단백질, 지방 등 약 40여 가지의 성분이 함유되어 있다(17). 호로파는 예로 부터 방광과 신장 등을 치료하는 데 사용되었으며, 최근 연구결 과에 따르면 남성의 정력증진 및 몸 속의 혈당과 인슐린의 균형을 유지하는 데에도 효과가 있고, 체중조절에도 효과가 있는 것으로 확인되어 활발히 연구가 진행 중에 있다(18-20). |
Becker HWG. Testicular dysfunction in systemic diseases. pp. 1150-1156. In: Principles and practice of endocrinology and metabolism, Backer KL (ed). Lippincott Co., Philadelphia, PA, USA (2000)
Araujo AB, Esche GR, Kupelian V, O'Donnell AB, Travison TG, Williams RE, Clark RV, McKinlay JB. Prevalence of symptomatic androgen deficiency in men. J. Clin. Endocr. Metab. 92: 4241-4247 (2007)
Buvat J, Maggi M, Gooren L, Guay AT, Kaufman J, Morgentaler A, Schulman C, Tan HM, Torres LO, Yassin A, Zitzmann M. Endocrine aspects of male sexual dysfunctions. J. Sex. Med. 7: 1627-1656 (2010)
Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM. Testosterone therapy in adult men with androgen deficiency syndromes: An endocrine society clinical practice guideline. J. Clin. Endocr. Metab. 91:1995-2010 (2006)
Nieschlag E, Swerdloff R, Behre HM, Gooren LJ, Kaufman JM, Legros JJ, Lunenfeld B, Morley JE, Schulman C, Wang C, Weidner W, Wu FCW. Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations. J. Androl. 27: 135-137 (2006)
Wang C, Nieschlag E, Swerdloff R, Behre HM, Hellstrom WJ, Gooren LJ, Kaufman JM, Legros JJ, Lunenfeld B, Morales A, Morley JE, Schulman C, Thompson IM, Weidner W, Wu FCW. ISA, ISSAM, EAU, EAA and ASA recommendations: Investigation, treatment and monitoring of late-onset hypogonadism in males. Aging Male 12: 5-12 (2009)
Singh P. Andropause: Current concepts. Indian J. Endocrinol. Metab. 17 (Suppl 3): S621-629 (2013)
Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM. Testosterone therapy in men with androgen deficiency syndromes: An Endocrine Society clinical practice guideline. J. Clin. Endocr. Metab. 95: 2536-2559 (2010)
Shores MM, Matsumoto AM. Testosterone, aging and survival: biomarker or deficiency. Curr. Opin. Endocrinol. Diabetes Obes. 21: 209-216 (2014)
Gray A, Feldman HA, McKinlay JB, Longcope C. Age, disease, and changing sex hormone levels in middle-aged men: Results of the Massachusetts male aging study. J. Clin. Endocr. Metab. 73: 1016-1025 (1991)
Wu FCW, Tajar A, Pye SR, Silman AJ, Finn JD, O'Neill TW, Bartfai G, Casanueva F, Forti G, Giwercman A, Huhtaniemi IT, Kula K, Punab M, Boonen S, Vanderschueren D. Hypothalamicpituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: The European male aging study. J. Clin. Endocr. Metab. 93: 2737-2745 (2008)
Gruenewald DA, Matsumoto AM. Testosterone supplementation therapy for older men: Potential benefits and risks. J. Am. Geriatr. Soc. 51: 101-115 (2003)
Rhoden EL, Morgentaler A. Risks of testosterone-replacement therapy and recommendations for monitoring. New Engl. J. Med. 350: 482-1492 (2004)
Muller M, van der Schouw YT, Thijssen JHH, Grobbee DE. Endogenous sex hormones and cardiovascular disease in men. J. Clin. Endocr. Metab. 88: 5076-5086 (2003)
Duru M, Erdogan Z, Duru A, Kucukgul A, Duzguner V, Kaya DA, Sahin A. Effect of seed powder of a herbal legume fenugreek (Trigonella foenum-graceum L.) on growth performance, body components, digestive parts, and blood parameters of broiler chicks. Pakistan J. Zool. 45: 1007-1014 (2013)
Yadav UC, Baquer NZ. Pharmacological effects of Trigonella foenum-graecum L. in health and disease. Pharm. Biol. 52: 243-254 (2014)
Kassem A, Al-Aghbari A, AL-Habori M, Al-Mamary M. Evaluation of the potential antifertility effect of fenugreek seeds in male and female rabbits. Contraception 73: 301-306 (2006)
Aswar U, Bodhankar SL, Mohan V, Thakurdesai PA. Effect of furostanol glycosides from Trigonella foenum-graecum on the reproductive system of male albino rats. Phytother. Res. 24: 1482-1488 (2010)
Lee JK, Kang DG, Lee HS. Vascular relaxation induced by aqueous extract of Lespedeza cuneata via the NO-cGMP pathway. J. Nat. Med. 66: 17-24 (2012)
Park SY, Kim HH. Effect of Lespedezea cuneata on the contraction of rabbit common carotid artery and corpus cavernosum. Korean J. Orient. Physiol. Pathol. 27: 809-817 (2013)
Isidori AM, Giannetta E, Gianfrilli D, Greco EA, Bonifacio V, Aversa A, Isidori A, Fabbri A, Lenzi A. Effects of testosterone on sexual function in men: Results of a meta-analysis. J. Clin. Endocrinol. 63: 381-394 (2005)
Derby CA, Zilber S, Brambilla D, Morales KH, McKinlay JB. Body mass index, waist circumference and waist to hip ratio and change in sex steroid hormones: The Massachusetts male ageing study. J. Clin. Endocrinol. 65 :125-131 (2006)
Morales A, Schulman CC, Tostain J, Wu FC. Testosterone deficiency syndrome (TDS) needs to be named appropriately: The importance of accurate terminology. Eur. Urol. 50: 407-409 (2006)
Taylor WG, Elder JL, Chang PR, Richards KW. Microdetermination of diosgenin from fenugreek (Trigonella foenum-graecum) seeds. J. Agr. Food Chem. 48: 5206-5210 (2000)
Sato K, Fujita S, Iemitsu M. Acute administration of diosgenin or dioscorea improves hyperglycemia with increases muscular steroidogenesis in STZ-induced type 1 diabetic rats. J. Steroid Biochem. 143: 152-159 (2014)
Murakami T, Kishi A, Matsuda H, Yoshikawa M. Medicinal foodstuffs XVII. Fenugreek seed. (3): Structures of new furostanol-type steroid saponins, trigoneosides Xa, Xb, XIb, XIIa, XIIb, and XIIIa, from the seeds of egyptian trigonella foenumgraecum L. Chem. Pharm. Bull. 48: 994-1000 (2000)
Shea JL, Wong PY, Chen Y. Free testosterone: Clinical utility and important analytical aspects of measurement. Adv. Clin. Chem. 63: 59-84 (2014)
Hammond GL. Diverse roles for sex hormone-binding globulin in reproduction. Biol. Reprod. 85: 431-441 (2011)
Duffy MJ. PSA in screening for prostate cancer: More good than harm or more harm than good? Adv. Clin. Chem. 66: 1-23 (2014)
Rick FG, Schally AV. Bench-to-bedside development of agonists and antagonists of luteinizing hormone-releasing hormone for treatment of advanced prostate cancer. Urol. Oncol.-Semin. O. I. 33: 270-274 (2015)
Barqawi A, Crawford ED. Testosterone replacement therapy and the risk of prostate cancer. Is there a link? Int. J. Impot. Res. 18: 323-328 (2006)
Schubert M, Jockenhovel F. Late-onset hypogonadism in the aging male (LOH): definition, diagnostic and clinical aspects. J. Endocrinol. Invest. 28: 23-27 (2005)
Kerksick CM, Wilborn CD, Campbell WI, Harvey TM, Marcello BM, Roberts MD, Parker AG, Byars AG, Greenwood LD, Almada AL, Kreider RB, Greenwood M. The effects of creatine monohydrate supplementation with and without D-pinitol on resistance training adaptations. J. Strength Cond. Res. 23: 2673-2682 (2009)
Schroeder, ET, Terk M, Sattler FR. Androgen therapy improves muscle mass and strength but not muscle quality: Results from two studies. Am. J. Physiol.-Endoc. M. 285: E16-E24 (2003)
Schroeder ET, Vallejo AF, Zheng L, Stewart Y, Flores C, Nakao S, Martinez C, Sattler FR. Six-week improvements in muscle mass and strength during androgen therapy in older men. J. Gerontol. A-Biol. 60: 1586-1592 (2005).
Moss JL, Crosnoe LE, Kim ED. Effect of rejuvenation hormones on spermatogenesis. Fertil. Steril. 99: 1814-1820 (2013)
Kovac J, Pastuszak AW, Lamb DJ, Lipshultz LI. Testosterone supplementation therapy in the treatment of patients with metabolic syndrome. Postgrad. Med. 126: 149-156 (2014)
Grober ED. Testosterone deficiency and replacement: Myths and realities. Cuaj-Can. Urol. Assoc. 8: S145-S147 (2014)
Kelly DM, Jones TH. Testosterone and cardiovascular risk in men. Front. Horm. Res. 43: 1-20 (2014)
Volpato S, Vigna GB, Fellin R. The benefit and risk of testosterone replacement therapy in older men: Effects on lipid metabolism. Acta Biomed. 81: 95-99 (2010)
Singh AB, Tamarkar AK, Narender T, Srivastava AK. Antihyperglycaemic effect of an unusual amino acid (4-hydroxyisoleucine) in C57BL/KsJ-db/db mice. Nat. Prod. Res. 24: 258-265 (2010)
Haeri MR, Limaki HK, Branford White CJ, White KN. Noninsulin dependent anti-diabetic activity of (2S, 3R, 4S) 4-hydroxyisoleucine of fenugreek (Trigonella foenum graecum) in streptozotocin-induced type I diabetic rats. Phytomedicine 19: 571-574 (2012)
Vinken M. The adverse outcome pathway concept: A pragmatic tool in toxicology. Toxicology 4: 158-165 (2013)
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.